(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Momentum: Crinetics' Acromegaly Study Data and Tesla's Morgan Stanley Boost

September 11th, 2023

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) has reported promising results from its Phase 3 PATHFNDR-1 study evaluating paltusotine, an oral once-daily investigational compound designed for acromegaly treatment. The study achieved its primary endp. Read more

Upcoming Earnings: High Tide, eGain, and iPower Take the Stage

September 11th, 2023

Some of the companies expected to report financial results on Thursday, September 14, are: High Tide Inc. (Nasdaq: HITI), a company in the cannabis industry, will release its financial and operational results for the third fiscal quarter of 2023 a. Read more

Earnings Due: Adobe, Copart, and Mitek Systems Set to Unveil

September 10th, 2023

Several companies are set to report their financial results on Thursday, September 14, including: Adobe Inc. (Nasdaq: ADBE), a renowned software company, is scheduled to release its third-quarter fiscal year 2023 results after the market closes.&n. Read more

Breaking Biotech Newsflash: Amgen, Gilead Sciences, and Merck

September 10th, 2023

Amgen Inc. (Nasdaq: AMGN) unveiled encouraging data from the CodeBreaK 101 clinical trial, showcasing the effectiveness of LUMAKRAS (sotorasib) plus chemotherapy (carboplatin and pemetrexed) in treating KRAS G12C-mutated advanced non-small cell lung . Read more

Earnings Countdown: InnovAge, Evolution Petroleum, and Edgio in the Spotlight

September 09th, 2023

Some of the companies expected to report financial results on Tuesday, September 12, are: InnovAge Holding Corp. (Nasdaq: INNV), a healthcare services provider, will be releasing its 2023 fiscal fourth-quarter financial results following the marke. Read more

FuelCell Energy, Casey's General Stores, and Skillsoft's Earnings Preview

September 09th, 2023

Among the companies slated to announce their financial results on Monday, September 11, are: FuelCell Energy, Inc. (Nasdaq: FCEL), a clean energy technology company, is set to release its third-quarter fiscal year 2023 results before the Stock Mar. Read more

A Preview: Oracle, Bowlero, and Mission Produce's Earnings in Focus

September 09th, 2023

Some of the companies expected to report financial results on Monday, September 11, include: Oracle Corporation (NYSE: ORCL), a global tech giant known for its database software and cloud computing solutions, is set to release its first-quarter fi. Read more

Administrative Law Judge Issues Initial Decision in FTC’s Case Against Intuit Inc.

September 08th, 2023

Order bars company from engaging in deceptive practices in the future Washington D.C. / CRWE PRESS RELEASE / September 8, 2023 -   In an initial decision announced today, the Federal Trade Commission’s Chief Administrativ. Read more

Bullish View on Spruce Biosciences; Kroger Posts Mixed Results

September 08th, 2023

Spruce Biosciences, Inc. (Nasdaq: SPRB), a pharmaceutical company, was upgraded from Market Perform to Outperform by SVB Leerink, accompanied by a revised price target increase from $3 to $9. Given that $SPRB closed at $2.23 on Thursday, this adju. Read more

Boeing Secures $474.5M Contract Action; Smartsheet Exceeds Wall Street Forecasts

September 08th, 2023

The Boeing Company (NYSE: BA) has secured an undefinitized contract action worth up to $474.5 million for the F-15 Japan Super Interceptor Program. This contract, part of the Foreign Military Sales (FMS) requirement, will involve the addition of the . Read more